论文部分内容阅读
BACKGROUND: Apurinic/apyrimidinic endonuclease 1 (APE1) has been recognized as a promising anticancer target in several malignancies,and its selective inhibitors such as APX3330 has been advanced in research recently.However,the anticancer effect of APE1 against ovarian cancer (OC) has not been well investigated.OBJECTIVE: In this study,we explored the biological function of APE 1 in ovarian cancer cells and its anticancer effect as a therapeutic target in OC.